Trimodal Therapy Approaches for Localized Rectal Cancer
Trimodal therapy approaches for localized rectal cancer continue to evolve as new data helps define the approaches that will best improve outcomes while reducing adverse effects, as well as which patients will benefit from these treatment methods.  Clinicians would benefit from education on relevant clinical trial results and how they may be best applied to clinical practice.
Category
  • Rectal Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Rectal Cancer
The determination of an optimal treatment plan for patients with rectal cancer is a complex process that is reliant on balancing the potential risks and benefits of each treatment option based on an individual patient’s characteristics. Clinicians must be educated about on emerging approaches to personalized treatment for patients with rectal cancer so that the most appropriate treatment options can be offered to each patient.
Category
  • Rectal Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Locoregional Management of Early-Stage Breast Cancer
Locoregional management strategies have considerably evolved.
Category
  • Breast Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Debate - What is Optimal First-Line Therapy for Chronic Lymphocytic Leukemia: Chemoimmunotherapy or Small Molecule Inhibitor Therapy?
The treatment landscape of first-line therapy for chronic lymphocytic leukemia (CLL) has evolved significantly in recent years. Educating the clinicians about the recent clinical advances and the benefits/risks associated with the use of chemoimmunotherapy vs. targeted therapy can help them to make informed clinical decisions and develop an individualized treatment plan.
Category
  • Chronic Lymphocytic Leukemia
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Talking to Patients about Cancer Treatment, Risk Factors, and Treatment Cessation during the COVID-19 Pandemic
Category
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Sequencing Therapy for Patients with Lung Cancer
The NCCN Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer Panels have recently started identifying and recommending preferred systemic therapy regimens for patients with NSCLC and small cell lung cancer based on clinical data and experience; because these are recent recommendations,
Category
  • Breast Cancer
  • Colorectal Cancer
  • Ovarian Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Cardiovascular Health and Risk Management in Cancer Survivors
As the population of cancer survivors continues to grow, it becomes increasingly important for clinicians providing survivorship care to be informed about the increased risk for cardiovascular disease in this population, particularly as related to specific cancer treatment exposures and cardiovas
Category
  • Survivorship
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Evidence-Based Approaches to Smoking Cessation in Patients with Cancer
Providing care for patients with cancer who smoke poses unique challenges for oncology teams already managing a complex disease, and standardized guidance on effective smoking cessation interventions for patients with cancer is needed.
Category
  • Smoking Cessation
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Key Considerations in Adopting a Value-Based Payment Model
The shift from fee-for-service to value is well underway; there are at least 20 payment reform models currently in existence or proposed for adoption, from payers and/or physician groups.
Category
  • Best Practices
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation
Use of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Real-World Issues
Cancer immunotherapy is a rapidly growing and dynamic field, particularly for diseases such as lung cancer where immune checkpoint inhibitors are an important component of treatment.
Category
  • Lung Cancers
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation

Pages